Routine use of tolvaptan in clinical practice may slow eGFR decline for patients with autosomal dominant polycystic kidney ...

Long-term tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD) yielded a 14% reduction in kidney function decline but had no influence on kidney growth.

Kidney function declined significantly more in the nephrolithiasis group over approximately 3 years: -16.53 vs -12.82 mL/min/1.73 m², the investigators reported. Nephrolithiasis was independently ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Expert Rev Cardiovasc Ther. 2008;6(5):601-608. The first Phase III clinical trial to study tolvaptan was the Study of Ascending Levels of Tolvaptan in Hyponatremia (SALT)-1/-2, which consisted of ...

Polycystic kidney disease (PKD) is a genetic disorder that leads to cyst formation in the kidneys, causing complications like kidney failure.

Last year marked an increase in federal securities class action filings, with plaintiffs filing 225 cases in 2024, up from 215 in 2023. Life sciences companies remained popular targets, accounting ...

Hepatotoxicity is damage or injury to the liver as a result of damaging or destructive agents such as drugs or industrial chemicals which are termed hepatotoxins. Acute liver failure arises ...

Dylan joined the KWCH team in January 2024. Moving to the Midwest was a step into a part of the country he has never been before as he was born in raised in South Louisiana baptized in Cajun culture.

Syndrome of Inappropriate Anti-Diuretic Hormone secretion, or SIADH, is a known complication of small-cell lung cancer (SCLC). SIADH makes your body produce too much of a hormone that causes your ...